Satomi et al. [12] showed the potential of the deficiency of MTAP expression by IHC as a predictive surrogate marker for CDKN2A HD in IDH-mutant astrocytomas. This evidence concerns the gene MTAP and astrocytoma (excluding glioblastoma).